Medicine Man Technologies, Inc.
Industrials · Services-Management Consulting Services · NV · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | |
|---|---|---|---|---|---|---|
| Revenue | $172.4M | $159.4M | $108.4M | $24.0M | $12.4M | $9.4M |
| Operating income | $3.3M | $12.9M | $10.4M | −$22.9M | −$17.1M | $2.2M |
| Net income | −$34.5M | −$18.5M | $14.5M | −$19.4M | −$17.0M | $948,915 |
| Total assets | $358.1M | $322.9M | $285.0M | $70.7M | $32.2M | $18.2M |
| Total liabilities | $238.9M | $190.7M | $151.5M | $28.9M | $5.6M | $1.1M |
| Equity | $119.3M | $132.2M | $133.6M | $41.8M | $26.6M | $17.1M |
| EPS (diluted) | $-0.66 | $-0.49 | $-0.06 | $-0.47 | $-0.50 | $0.03 |
| Shares out. | 55.2M | 45.6M | 42.2M | 40.0M | 28.0M | 24.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- 1.9%
- Net margin
- −20.0%
- Return on equity
- −29.0%
- Return on assets
- −9.6%
- Return on capital (ROCE)
- 1.1%
- Liabilities / assets
- 66.7%
- Debt / equity
- 2.00×
- Book value / share
- $2.16
- Revenue growth (YoY)
- 8.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -0.18distress
- Accruals / assets
- −13.1%clean
- Beneish M-Score
- -3.13normal
- Piotroski F-Score
- 2/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 1 warning● 4 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Apr 1, 2025
- NT 10-Qmissed a reporting deadline ↗Nov 15, 2024
- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
- NT 10-Qmissed a reporting deadline ↗May 16, 2024
- NT 10-Qmissed a reporting deadline ↗May 15, 2019
- NT 10-Kmissed a reporting deadline ↗Mar 29, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Parco James EPassive (13G)Apr 2, 2024
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Debt acceleration / triggering event · Regulation FD disclosureOct 14, 2025
- Director / officer changeJul 18, 2025
- Director / officer changeMay 6, 2025
- Director / officer changeApr 21, 2025
- Debt acceleration / triggering eventMar 13, 2025
- Debt acceleration / triggering event · Director / officer changeDec 12, 2024
- Prior financials not reliable (restatement)Dec 4, 2024
- Results of operationsAug 13, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4OWNERSHIP DOCUMENTDec 9, 2025
- 15-12GNov 18, 2025
- 8-KFORM 8-KOct 14, 2025
- 8-KFORM 8-KJul 18, 2025
- 8-KFORM 8-KMay 6, 2025
- 8-KFORM 8-KApr 21, 2025
- NT 10-KApr 1, 2025
- 8-KFORM 8-KMar 13, 2025
- 8-KFORM 8-KDec 12, 2024
- 8-KFORM 8-KDec 4, 2024
- NT 10-QNov 15, 2024
- 4OWNERSHIP DOCUMENTOct 7, 2024
- 4OWNERSHIP DOCUMENTOct 7, 2024
- 4OWNERSHIP DOCUMENTOct 7, 2024
- NT 10-QFORM NT 10-QAug 15, 2024
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.